Homocysteine-Lowering Interventions in Chronic Kidney Disease

The incidence of cardiovascular events and mortality is higher in patients with chronic kidney disease (CKD) compared to the general population. Homocysteine (Hcy) appears to be an independent risk factor for cardiovascular diseases in general populations and patients with CKD. Further, hyperhomocys...

Descripción completa

Detalles Bibliográficos
Autores principales: Badri, Shirinsadat, Vahdat, Sahar, Seirafian, Shiva, Pourfarzam, Morteza, Gholipur-Shahraki, Tahereh, Ataei, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809459/
https://www.ncbi.nlm.nih.gov/pubmed/35198504
http://dx.doi.org/10.4103/jrpp.jrpp_75_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809459/
https://www.ncbi.nlm.nih.gov/pubmed/35198504
http://dx.doi.org/10.4103/jrpp.jrpp_75_21

Ejemplares similares